Search Studies
Study of the Drug Inotuzumab Ozogamicin in Patients with Disseminated B-cell Lymphoblastic Lymphoma
The purpose of this study is to find out if the study drug, Inotuzumab Ozogamicin, can help treat certain types of leukemia. The study drug will be given along with the usual chemotherapy.
Study Topics
Studying a New Treatment for Childhood Leukemia
The purpose of this study is to learn how safe and helpful a medicine called inotuzumab ozogamicin is when used with chemotherapy. This treatment is for children and young adults whose B‑cell leukemia has come back or did not respond to past treatment. Researchers want to see how well this treatment works and what side effects it may cause.
Study Topics
Testing the Use of Daratumumab-Hyaluronidase for Treating T Cell Acute Lymphoblastic Leukemia
Sometimes after a patient with T cell acute lymphoblastic leukemia (T-ALL) has been treated with chemotherapy the leukemia remains at a very low level. This low level of leukemia is called minimal residual disease (MRD). People with MRD have a higher risk for leukemia coming back again. The purpose of this study is to find out if daratumumab and hyaluronidase can get rid of the MRD.
Study Topics
Studying a New Treatment for Kids and Teens with Leukemia
The purpose of this study is learn more about a new treatment for children, teens, and young adults with leukemia. The treatment uses regular cancer medicine plus special medicines called dasatinib or imatinib and blinatumomab. The goal is to see if this new combination works better and has fewer side effects than the usual treatment.
Study Topics
A Study of the Drug ABBV-383 for Patients with AL Amyloidosis
The purpose of this study is to learn more about the study drug ABBV-383 in patients with amyloidosis. We want to find the best dose and learn about the safety and effects of the study drug.
Study Topics
Studying New Treatments for Children and Young Adults With Relapsed B-ALL
The purpose of this study is to look at a new way to treat a blood cancer called B-ALL that has come back after prior treatment. Researchers will see if the medicine combination of blinatumomab and nivolumab is more effective than blinatumomab alone. The goal is to find safer treatments that help people stay healthy longer.
Study Topics